Literature DB >> 15904646

Predictors of left main or three-vessel disease in patients who have acute coronary syndromes with non-ST-segment elevation.

Masami Kosuge1, Kazuo Kimura, Toshiyuki Ishikawa, Toshiaki Ebina, Tomoaki Shimizu, Kiyoshi Hibi, Noritaka Toda, Yoshio Tahara, Kengo Tsukahara, Masahiko Kanna, Jyunn Okuda, Naoki Nozawa, Hiroyuki Ozaki, Hideto Yano, Satoshi Umemura.   

Abstract

To identify an early, simple, noninvasive predictor of left main (LM) or 3-vessel disease (3-VD), we retrospectively studied clinical variables on admission in 310 patients with acute coronary syndromes with non-ST-segment elevation. Univariate analysis indicated that many factors were related to LM/3-VD. Multivariate analysis showed that ST-segment elevation in lead aVR of >/=0.5 mm was the strongest predictor of LM/3-VD, followed by positive troponin T (odds ratio 19.7, p <0.001, and odds ratio 3.08, p = 0.048, respectively). ST-segment elevation in lead aVR of >/=0.5 mm and positive troponin T identified LM/3-VD with sensitivities of 78% and 62%, specificities of 86% and 59%, positive predictive values of 57% and 26%, and negative predictive values of 95% and 87%, respectively (p <0.05). Our findings suggest that in patients with non-ST-segment elevation acute coronary syndromes, ST-segment elevation in lead aVR of >/=0.5 mm and positive troponin T on admission (especially the former) are useful predictors of LM/3-VD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15904646     DOI: 10.1016/j.amjcard.2005.01.085

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

1.  aVR - the forgotten lead.

Authors:  Anil George; Pradeep S Arumugham; Vincent M Figueredo
Journal:  Exp Clin Cardiol       Date:  2010

Review 2.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

3.  The prognostic value of T wave amplitude in lead aVR in males.

Authors:  Swee Y Tan; Gregory Engel; Jonathan Myers; Marcus Sandri; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-04       Impact factor: 1.468

Review 4.  Utility of lead aVR for identifying the culprit lesion in acute myocardial infarction.

Authors:  Jørgen Tobias Kühl; Ronan M G Berg
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

Review 5.  Significance of lead aVR in acute coronary syndrome.

Authors:  Akira Tamura
Journal:  World J Cardiol       Date:  2014-07-26

6.  Prognostic significance of T-wave amplitude in lead aVR in heart failure patients with narrow QRS complexes.

Authors:  Kentarou Okuda; Eiichi Watanabe; Kan Sano; Tomoharu Arakawa; Mayumi Yamamoto; Yoshihiro Sobue; Tatsushi Uchiyama; Yukio Ozaki
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

7.  Easy clinical-ECG criteria to suspect total occlusion of left main in acute coronary syndrome.

Authors:  Miquel Fiol; Andrés Carrillo; Antonio Bayes de Luna
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

8.  A Case of Acute Myocardial Infarction With ST-Segment Elevation in a Lead Augmented Right Vector Caused by a Left Main Coronary Artery Vasospasm.

Authors:  Kyong Yeun Jung; Tae Soo Kang
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

9.  Acute coronary syndromes presenting with transient diffuse ST segment depression and st segment elevation in lead aVR not caused by "acute left main coronary artery occlusion": description of two cases.

Authors:  Edward Kim; Yochai Birnbaum
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

10.  Prognostic value of positive T wave in lead aVR in patients with non-ST segment myocardial infarction.

Authors:  Ahmad Separham; Bahram Sohrabi; Arezou Tajlil; Leili Pourafkari; Robabeh Sadeghi; Samad Ghaffari; Nader D Nader
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-19       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.